Why the study?
Does interferon-λ cure persistent murine norovirus infection in mice?
Does interferon-λ cure persistent murine norovirus infection in mice?
IFN-λ cures persistent murine norovirus infection in the gastrointestinal tract independent of adaptive immunity, suggesting therapeutic potential for enteric viral infections.
Answers are grounded in this paper and cite their sources.
IFN-λ merits investigation for human enteric viruses; leaves open translation from this murine model.
Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-α (IFN-α) and IFN-β prevented the systemic spread of murine norovirus (MNoV), only IFN-λ controlled persistent enteric infection. Infection-dependent induction of IFN-λ was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-λ cured mice in a manner requiring nonhematopoietic cell expression of the IFN-λ receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-λ for curing virus infections in the gastrointestinal tract.
No takes yet. Share an insight, caveat, or question.
Nice et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: